close

Clinical Trials

1 2 3 4 5 187
Number of results: 3721

Excel print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2017-02-16 GBT440 1 Global Blood Therapeutics (USA - CA) Hematological diseases
2017-02-16 ART-I02 rheumatoid arthritis 1b Arthrogen (The Netherlands) Autoimmune diseases – Inflammatory diseases - Rheumatic diseases
2017-02-16 AGT-181 (fusion protein of anti-human insulin receptor monoclonal antibody and alpha-L-iduronidase; HIRMAb-IDUA) mucopolysaccharidosis I (Hurler syndrome) 1-2 Armagen (USA - CA) Rare diseases - Genetic diseases
2017-02-16 TRC105 advanced angiosarcoma 3 Tracon Pharmaceuticals (USA - CA) Cancer - Oncology
2017-02-16 TransCon Growth Hormone growth hormone deficiency 2 Ascendis Pharma (Denmark) Endocrine diseases - Hormonal diseases
2017-02-15 ATB200 and AT2221 Pompe disease 1-2 Amicus Therapeutics (USA - NJ) Genetic diseases - Rare diseases - Metabolic diseases
2017-02-15 TPIV 200 (multi-epitope folate receptor alpha peptide vaccine with GM-CSF adjuvant) triple-negative breast cancer (TNBC) 2 Tapimmune (USA - FL) Cancer - Oncology
2017-02-15 tenapanor hyperphosphatemia in end-stage renal disease patients on hemodialysis 3 Ardelyx (USA - CA)
2017-02-14 GZ/SAR402671 Parkinson's disease 2 Genzyme (USA - MA), a Sanofi company (France) Neurodegenerative diseases
2017-02-14 GBT440 preclinical Global Blood Therapeutics (USA - CA)
2017-02-14 verubecestat (MK-8931) Alzheimer's Disease 2-3 Merck&Co (USA - NJ) Neurodegenerative diseases
2017-02-14 Acarovac MPL (monophosphoryl lipid A) house dust mite allergy 1 Allergy Therapeutics (UK) Allergic diseases
2017-02-14 doravirine (MK-1439) HIV-1 infection 3 Merck&Co (USA - NJ) Infectious diseases
2017-02-14 Genvoya® (elvitegravir 150 mg, cobicistat 150 mg, emtricitabine 200 mg and tenofovir alafenamide 10 mg or E/C/F/TAF) HIV-1 infection 3 Gilead (USA - CA) Infectious diseases
2017-02-13 navicixizumab - anti-DLL4/VEGF bispecific antibody (OMP-305B83) ovarian cancer 1b-2 OncoMed Pharmaceuticals (USA - CA) Cancer - Oncology
2017-02-13 BAY1834845 pelvic inflammatory disease 1 Bayer (Germany) Inflammatory diseases
2017-02-13 Pexa-Vec (pexastimogene devacirepvec) metastatic and/or locally advanced solid tumors 1 Transgene (France) Centre Leon Berard (France) Cancer - Oncology
2017-02-13 Bekinda™(extended-release formulation of ondansetron) acute gastroenteritis 3 Redhill Biopharma (Israel) Inflammatory diseases - Gastrointestinal diseases
2017-02-13 bictegravir (GS-9883) HIV-1 Infection 2 Gilead Sciences (USA - CA) Infectious diseases
2017-02-13 GS-CA1, HIV-1 capsid inhibitors HIV-1 infection preclinical Gilead Sciences (USA - CA) Infectious diseases